[go: up one dir, main page]

NO20055668D0 - Beta-amyloidinhibitorer og anvendelse derav - Google Patents

Beta-amyloidinhibitorer og anvendelse derav

Info

Publication number
NO20055668D0
NO20055668D0 NO20055668A NO20055668A NO20055668D0 NO 20055668 D0 NO20055668 D0 NO 20055668D0 NO 20055668 A NO20055668 A NO 20055668A NO 20055668 A NO20055668 A NO 20055668A NO 20055668 D0 NO20055668 D0 NO 20055668D0
Authority
NO
Norway
Prior art keywords
beta
amyloid inhibitors
amyloid
inhibitors
Prior art date
Application number
NO20055668A
Other languages
English (en)
Other versions
NO20055668L (no
Inventor
Luca Barbero
Silvio Traversa
Pierandrea Esposito
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems filed Critical Applied Research Systems
Publication of NO20055668L publication Critical patent/NO20055668L/no
Publication of NO20055668D0 publication Critical patent/NO20055668D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Neurosurgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Navigation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20055668A 2003-04-30 2005-11-30 Beta-amyloidinhibitorer og anvendelse derav NO20055668D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03101202 2003-04-30
PCT/EP2004/004807 WO2004096845A2 (en) 2003-04-30 2004-04-29 Beta-amyloid inhibitors and use thereof

Publications (2)

Publication Number Publication Date
NO20055668L NO20055668L (no) 2005-11-30
NO20055668D0 true NO20055668D0 (no) 2005-11-30

Family

ID=33395961

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20055668A NO20055668D0 (no) 2003-04-30 2005-11-30 Beta-amyloidinhibitorer og anvendelse derav

Country Status (7)

Country Link
US (1) US20070293422A1 (no)
EP (1) EP1618129A2 (no)
JP (1) JP2007523848A (no)
AU (1) AU2004234076A1 (no)
CA (1) CA2522460A1 (no)
NO (1) NO20055668D0 (no)
WO (1) WO2004096845A2 (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8101578B2 (en) 2006-04-28 2012-01-24 Kagoshima University Amyloid [β] Beta fibrillogenesis-inhibiting peptide
US9284351B2 (en) * 2011-05-31 2016-03-15 Hutchison Biofilm Medical Solutions Ltd. Dispersion and detachment of cell aggregates
KR102475326B1 (ko) * 2022-01-27 2022-12-07 한국기초과학지원연구원 신규한 펩타이드 유사체 및 이를 포함하는 알츠하이머 병 예방 조성물
CN114578066B (zh) * 2022-05-07 2022-08-19 北京第一生物化学药业有限公司 检测β-淀粉样蛋白的产品和方法
CN114594272B (zh) * 2022-05-07 2022-08-23 北京第一生物化学药业有限公司 用于检测β-淀粉样蛋白的产品和方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2214247C (en) * 1995-03-14 2004-02-10 Praecis Pharmaceuticals Incorporated Modulators of amyloid aggregation
US6399584B1 (en) * 1998-03-18 2002-06-04 Institute Curie Pharmaceutical composition containing ezrin mutated on tyrosine 353
CA2350919A1 (en) * 1998-11-13 2000-05-25 Cyclacel Limited Antennapedia homeodomain helix 3 derived translocation vectors
US6303576B1 (en) * 1999-04-21 2001-10-16 Adherex Technologies Inc. Compounds and methods for modulating β-catenin mediated gene expression
GB9917724D0 (en) * 1999-07-28 1999-09-29 Medical Res Council Peptides
AU2002250034A1 (en) * 2001-02-08 2002-08-19 Sequitur, Inc. Methods of light activated release 0f ligands from endosomes
FR2829940A1 (fr) * 2001-09-27 2003-03-28 Synt Em Compositions pour la vectorisation d'anticorps a travers la barriere hematoencephalique et leur utilisation pour le diagnostic ou le traitement des maladies du systeme nerveux central

Also Published As

Publication number Publication date
CA2522460A1 (en) 2004-11-11
EP1618129A2 (en) 2006-01-25
AU2004234076A1 (en) 2004-11-11
JP2007523848A (ja) 2007-08-23
NO20055668L (no) 2005-11-30
WO2004096845A2 (en) 2004-11-11
US20070293422A1 (en) 2007-12-20
WO2004096845A3 (en) 2005-01-06

Similar Documents

Publication Publication Date Title
DK1592686T3 (da) Gyrase-inhibitorer og anvendelser deraf
IS6934A (is) Nýjar spírótrísýklískar afleiður og notkun þeirrasem fosfódíesterasa-7-hindrar
NO2017017I1 (no) umeklinidium og vilanterol
NO20054453D0 (no) P38 inhibitorer og fremgangsmater for anvendelse derav
IS8305A (is) Bindandi smíðar og aðferðir við notkun þeirra
NO20052524D0 (no) Aminerte isofiavonoidderivater og anvendelse derav
DK1997809T3 (da) P38-inhibitorer og fremgangsmåder til anvendelse deraf
NO20040640L (no) Anordning og fremgangsmate
DK1465615T3 (da) Tricykliske bisenonderivater og fremgangsmåder til anvendelse heraf
IS7977A (is) Samsetningar og aðferð til samsettra meðferðar
IS8153A (is) Ónæmisbælandi efnasambönd og efnablöndur
DK1648426T3 (da) Benzimidazolderivater og anvendelse heraf som proteinkinaseinhibitorer
NO20044915L (no) C-aryl-glukosid SGLT2 inhibitorer og metode
NO20053974D0 (no) Tienopyrimidinforbindelser og anvendelse derav.
DK1711207T3 (da) Interferon-alpha-antistoffer og anvendelse heraf
IS8146A (is) Setnar 3-alkýl og 3-alkenýl asetidín afleiður
IS8392A (is) Heterósýklískir hindrar MEK og notkun þeirra
DK1251848T3 (da) Gyraseinhibitorer og anvendelse deraf
IS2504B (is) Fosfónóoxýkínasólínafleiður og lyfjafræileg notkun þeirra
DK1771421T3 (da) N-hydroxyamidderivater og anvendelse deraf
IS7725A (is) Imidazólópyridín og aðferðir við framleiðslu og notkun þeirra
IS8329A (is) Kínólínafleiður og notkun þeirra í meðferð
DK1675852T3 (da) Heterocykliske 7-amino-alkylidenyl-quinoloner og -naphthyridoner
NO20033854L (no) N-but-3-enyl-norbuprenorfin og fremgangsmåter for anvendelse
NO20053593D0 (no) Arylalkylkarbamat-derivater, fremgangsmate og anvendelse derav i terapi

Legal Events

Date Code Title Description
CREP Change of representative

Representative=s name: ONSAGERS AS, POSTBOKS 6963 ST OLAVS PLASS, 0130 OS

FC2A Withdrawal, rejection or dismissal of laid open patent application